Enliven Therapeutics, Inc. (ELVN)
Total Valuation
ELVN has a market cap or net worth of $727.30 million. The enterprise value is $474.10 million.
Market Cap | 727.30M |
Enterprise Value | 474.10M |
Important Dates
The last earnings date was Thursday, March 14, 2024, after market close.
Earnings Date | Mar 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ELVN has 41.35 million shares outstanding. The number of shares has increased by 1,037.74% in one year.
Shares Outstanding | 41.35M |
Shares Change (YoY) | +1,037.74% |
Shares Change (QoQ) | +0.39% |
Owned by Insiders (%) | 6.96% |
Owned by Institutions (%) | 80.99% |
Float | 12.51M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.96 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.28, with zero debt.
Current Ratio | 10.28 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.60% and return on invested capital (ROIC) is -33.97%.
Return on Equity (ROE) | -26.60% |
Return on Assets (ROA) | -25.20% |
Return on Capital (ROIC) | -33.97% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.56M |
Employee Count | 46 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.12% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -25.12% |
50-Day Moving Average | 15.85 |
200-Day Moving Average | 15.17 |
Relative Strength Index (RSI) | 56.02 |
Average Volume (30 Days) | 138,126 |
Short Selling Information
The latest short interest is 4.33 million, so 10.47% of the outstanding shares have been sold short.
Short Interest | 4.33M |
Short Previous Month | 4.33M |
Short % of Shares Out | 10.47% |
Short % of Float | 34.61% |
Short Ratio (days to cover) | 41.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -83.53M |
Pretax Income | -71.58M |
Net Income | -71.58M |
EBITDA | -70.98M |
EBIT | -71.58M |
Earnings Per Share (EPS) | -$2.01 |
Balance Sheet
The company has $253.20 million in cash and no debt, giving a net cash position of $253.20 million or $6.12 per share.
Cash & Cash Equivalents | 253.20M |
Total Debt | n/a |
Net Cash | 253.20M |
Net Cash Per Share | $6.12 |
Equity / Book Value | 245.91M |
Book Value Per Share | 5.95 |
Working Capital | 240.26M |
Cash Flow
In the last 12 months, operating cash flow was -$61.27 million and capital expenditures -$149,000, giving a free cash flow of -$61.42 million.
Operating Cash Flow | -61.27M |
Capital Expenditures | -149,000 |
Free Cash Flow | -61.42M |
FCF Per Share | -$1.73 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELVN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,037.74% |
Shareholder Yield | -1,037.74% |
Earnings Yield | -9.84% |
FCF Yield | -8.44% |
Analyst Forecast
The average price target for ELVN is $27.00, which is 53.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $27.00 |
Price Target Difference | 53.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 24, 2023. It was a reverse split with a ratio of 1:4.
Last Split Date | Feb 24, 2023 |
Split Type | Reverse |
Split Ratio | 1:4 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |